Showing results (1751-1760 of 6,713) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|October 11, 2021
MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1 [Retraction]Oncotargets and Therapy|April 15, 2022
Treatment of PD-1 Inhibitor-Associated Toxic Epidermal Necrolysis: A Case Report and Brief ReviewYidong Zhao, Yuzhen Cao, Xiuyu Wang, et al.Oncotargets and Therapy|September 21, 2018
Suppression of c-MET overcomes erlotinib resistance in tongue cancer cellsKeqiang Huang, Dongxu LiuOncotargets and Therapy|September 21, 2018
Prognostic significance of NANOG expression in solid tumors: a meta-analysisLingqiong Zhao, Jie Liu, Shu Chen, et al.Oncotargets and Therapy|July 10, 2010
Update on the rational use of Y-ibritumomab tiuxetan in the treatment of follicular lymphomaMartina Lehnert, Heinz Ludwig, Niklas ZojerOncotargets and Therapy|February 4, 2011
The spectrum of use of rituximab in chronic lymphocytic leukemiaAlessandra Tedeschi, Eleonora Vismara, Francesca Ricci, et al.Oncotargets and Therapy|February 4, 2011
Survivin-T34A: molecular mechanism and therapeutic potentialJonathan R Aspe, Nathan R WallOncotargets and Therapy|December 4, 2010
Polyclonal B-cell lymphocytosis with binucleated lymphocytes (PPBL)Xavier Troussard, Edouard Cornet, Jean-François Lesesve, et al.Oncotargets and Therapy|December 4, 2010
Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signalingWessen Maruwge, Pádraig D'Arcy, Annika Folin, et al.Oncotargets and Therapy|September 22, 2010
Temsirolimus in the treatment of relapsed or refractory mantle cell lymphomaNousheen Samad, Anas YounesPageof 672